Related Experiment Video
Updated: Mar 16, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
Published on: May 5, 2018
Comorbid Conditions in Neonates With Congenital Heart Disease
Ganga Krishnamurthy1, Veniamin Ratner, Emile Bacha
11Department of Pediatrics, Section of Neonatology and Perinatology, Neonatal Cardiac Care, Columbia University College of Physicians and Surgeons, New York-Presbyterian Morgan Stanley Children's Hospital, New York, NY. 2Department of Pediatrics, Section of Neonatology and Perinatology, Columbia University College of Physicians and Surgeons, New York- Presbyterian Morgan Stanley Children's Hospital, New York, NY. 3Department of Surgery, Congenital and Pediatric Cardiac Surgery, Columbia University College of Physicians and Surgeons, New York-Presbyterian Morgan Stanley Children's Hospital, New York, NY. 4Department of Surgery, Columbia University College of Physicians and Surgeons, New York-Presbyterian Morgan Stanley Children's Hospital, New York, NY.
Insights
Infants with congenital heart disease and noncardiac anomalies face higher mortality risks. Optimal outcomes require a collaborative, interdisciplinary approach for these complex cases.
Area of Science:
- Pediatric Cardiology
- Neonatology
- Medical Genetics
Background:
- Congenital heart disease (CHD) significantly increases mortality risk when associated with noncardiac anomalies.
- Prematurity in infants with CHD presents unique challenges due to immature organ systems.
- Management of these complex cases requires specialized, coordinated care.
Purpose of the Study:
- To review the pathophysiology of major noncardiac anomalies in infants with CHD.
- To discuss the clinical impact of these anomalies and prematurity on infants with CHD.
- To outline current treatment strategies for these complex pediatric cases.
Main Methods:
- Literature review of MEDLINE and PubMed databases.
- Synthesis of information on pathophysiology, clinical impact, and treatment.
- Focus on major noncardiac anomalies and prematurity in the context of CHD.
Main Results:
- Noncardiac anomalies significantly elevate mortality in infants with CHD.
- Several noncardiac anomalies necessitate neonatal surgery for survival.
- Premature infants with CHD experience compounded physiological challenges.
Conclusions:
- A collaborative, interdisciplinary approach is essential for optimal outcomes in premature infants and those with multiple congenital anomalies.
- Effective management hinges on addressing both cardiac and noncardiac issues.
- Early and coordinated interventions improve survival and quality of life.
Objectives:
The objectives of this review are to discuss the pathophysiology, clinical impact and treatment of major noncardiac anomalies, and prematurity in infants with congenital heart disease.
Data Source:
MEDLINE and PubMed.
Conclusion:
Mortality risk is significantly higher in patients with congenital heart disease and associated anomalies compared with those in whom the heart defect occurs in isolation. Although most noncardiac structural anomalies do not require surgery in the neonatal period, several require surgery for survival. Management of such infants poses multiple challenges. Premature infants with congenital heart disease face challenges imposed by their immature organ systems, which are susceptible to injury or altered function by congenital heart disease and abnormal circulatory physiology independent of congenital heart disease. For optimal outcomes in premature infants or in infants with multiple congenital anomalies, a collaborative interdisciplinary approach is necessary.
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure I: Introduction
Mitral Stenosis I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Mitral Regurgitation I: Introduction
Heart Failure III: Clinical Manifestations

